li xiaolin
Shandong Entry-Exit Inspection and Quarantine Bureau
Qingdao, China
Review Editor
Pharmacology of Anti-Cancer Drugs
Editors
- Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- Editorial board
Type at least 3 characters
Editors
Shape the future of research in your field
Join the board
Review Editors
tian xie
Hangzhou Normal University
Hangzhou, China
Review Editor
Pharmacology of Anti-Cancer Drugs
chengguo xing
University of Florida
Gainesville, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
puyuan xing
Center for National Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, China
Review Editor
Pharmacology of Anti-Cancer Drugs
yan xiong
West China Hospital, Sichuan University
Chengdu, China
Review Editor
Pharmacology of Anti-Cancer Drugs
daozhi xu
Shenyang Medical College
Shenyang, China
Review Editor
Pharmacology of Anti-Cancer Drugs
guang xu
Marian University
Indianapolis, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
haibo xu
Chengdu University of Traditional Chinese Medicine
Chengdu, China
Review Editor
Pharmacology of Anti-Cancer Drugs
huanli xu
Capital Medical University
Beijing, China
Review Editor
Pharmacology of Anti-Cancer Drugs
liang xu
University of Kansas
Lawrence, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
maolei xu
Binzhou Medical University
Binzhou, China
Review Editor
Pharmacology of Anti-Cancer Drugs
meng xu
Dalian Municipal Central Hospital
Dalian, China
Review Editor
Pharmacology of Anti-Cancer Drugs
wenxia xu
Zhejiang University
Hangzhou, China
Review Editor
Pharmacology of Anti-Cancer Drugs
yubin xu
Taizhou Central Hospital
Taizhou, China
Review Editor
Pharmacology of Anti-Cancer Drugs
zhiwei xu
Jiangsu University
Zhenjiang, China
Review Editor
Pharmacology of Anti-Cancer Drugs
zhou xunian
MD Anderson Cancer Center
Houston, United States
Review Editor
Pharmacology of Anti-Cancer Drugs